Onvitrelin ucalontide (Phor18-LHRH (338613); EP-100) 是一种促黄体生成素释放激素 (LHRH) 受体配体。Onvitrelin ucalontide 可结合癌细胞上的功能性 LHRH 受体,介导靶向细胞毒性。Onvitrelin ucalontide 可降低异种移植模型中的肿瘤体积、重量和存活肿瘤细胞数量。Onvitrelin ucalontide 可用于乳腺癌、卵巢癌、前列腺癌的研究。
产品信息
| Product Name | Onvitrelin ucalontide(Phor18-LHRH (338613); EP-100) |
| Biological activity | Onvitrelin ucalontide (Phor18-LHRH (338613); EP-100) is a luteinizing hormone-releasing hormone (LHRH) receptor ligand. Onvitrelin ucalontide binds to functional LHRH receptors on cancer cells and mediates targeted cytotoxicity. Onvitrelin ucalontide reduces tumor volume, weight and the number of viable tumor cells in xenograft models. Onvitrelin ucalontide can be used for the research of breast cancer, ovarian cancer and prostate cancer. |
| Molecular Weight | 3316.94 |
| Formula | C163H243N43O32 |
| CAS Number | 1174415-90-7 |
| Sequence | Lys-Phe-Ala-Lys-Phe-Ala-Lys-Lys-Phe-Ala-Lys-Phe-Ala-Lys-Lys-Phe-Ala-Lys-Gln-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly |
| Sequence Shortening | KFAKFAKKFAKFAKKFAKQHWSYGLRPG |
| Storage | 请按分析证书所列推荐条件保存产品。 |


联系我们